vktx stock forecast zacks

1 VK2809 which is an oral liver selective agonist of the thyroid hormone receptor. Common Stock VKTX.

Stock Forecast Zacks Mars Architects Com

1 VK5211 which is being developed for acute rehabilitation following non-elective hip fracture surgery.

. Viking Therapeutics Inc Stock Market info Recommendations. Viking Therapeutics Inc. Youll find the Viking Therapeutics share forecasts stock quote and buy sell signals belowAccording to present data Viking Therapeuticss VKTX shares and potentially its market environment have been in bearish.

On April 13 2016 Viking Therapeutics Inc. Since then VKTX stock has decreased by 335 and is now trading at 337. If a stocks EPS consensus estimate is 110 now vs.

Shares of Viking Therapeutics Inc. The details of the Phase 1 trial will be announced upon study initiation however we. Read our earnings report guide before you consider the forecast information when making investment decisions.

The companys lead compounds include. Ad Invest to Achieve Your Goals. Learn More About Long Term Investment Stocks.

Viking Therapeutics Inc. The Viking Therapeutics stock price fell by -030 on the last day Friday 18th Mar 2022 from 338 to 337. Enrollment of Phase 2 Trial of VK2809 Nearing Completion.

Ad Our Strong Buys Double the SP. Wall Street analysts expect Viking Therapeutics Inc. On November 5 2019 Viking Therapeutics Inc.

Stock Price and Discussion Stocktwits. The average twelve-month price target for Viking Therapeutics is 1550 with a high price target of 2100 and a low price target of 1000. VKTX announced the closing of a previously announced public offering of 75 million shares of its common stock and warrants to purchase up to 75 million shares of common stock at a public offering price of 125 per share.

Viking Therapeutics stock was trading at 507 on March 11th 2020 when COVID-19 Coronavirus reached pandemic status according to the World Health Organization. According to the issued ratings of 7 analysts in the last year the consensus rating for Viking Therapeutics stock is Buy based on the current 7 buy ratings for VKTX. VKTX have gained 05 over the past four weeks to close the last trading session at 573 but there could still be.

During the day the stock fluctuated 758 from a day low at 330 to a day high of 355. The price has been going up and down for this period and there has been a 597 gain for the last 2 weeks. NASDAQVKTX - Get Rating to post 020 earnings per share for the current fiscal quarter according to Zacks Investment ResearchZero analysts have provided estimates for Viking Therapeutics earnings with the highest EPS estimate coming in at 018 and the lowest estimate coming in at 023.

Based On Fundamental Analysis. The views and opinions expressed herein are the views and opinions of the author and do. Explore Investment Resources Portfolios Market Commentary More at Zacks.

Ad Find Top Rated Stocks Information to Help You Beat the Market. P2b Trial to Initiate in 4Q19. The companys lead compounds include.

Find real-time VKTX - Viking Therapeutics Inc stock quotes company profile news and forecasts from CNN Business. NASDAQVKTX is a biopharmaceutical company developing treatments for metabolic and endocrine disorders. READ THE FULL VKTX RESEARCH REPORT.

VKTX 343 000 000 Post-Market 015 437 17648. NASDAQVKTX provided a business update which included the announcement that the Investigational New Drug IND application for VK2809 has been. NASDAQ Updated Feb 25 2022 1152 PM.

By David Bautz PhD NASDAQVKTX READ THE FULL VKTX RESEARCH REPORT Business Update VK0214 IND Filed Viking Therapeutics Inc. Click here - the VKTX analysis is free About Price and. NASDAQVKTX recently announced that the IND for VK0214 has been filed and a Phase 1 trial will commence upon clearance of the IND.

Volume has increased on the last day. VKTX VIKING THERAPEUTICS INC. Learn more on VKTXs analyst rating.

By David Bautz PhD NASDAQVKTX READ THE FULL VKTX RESEARCH REPORT Business Update Viking Therapeutics Inc. IND Filed for VK2809. Zacks Investment Research is releasing its prediction for VKTX based on the 1-3 month trading system that nearly triples the SP 500.

View which stocks have been most impacted by COVID-19. VKTX stock quote history news and other vital information to help you with your stock trading and investing. Zacks Investment Research is releasing its prediction for VKTX based on the 1-3 month trading system that nearly triples the SP 500.

NASDAQVKTX is a biopharmaceutical company developing treatments for metabolic and endocrine disorders. 100 the week before that will be reflected as a. Find the latest Viking Therapeutics Inc.

Find Out What Services a Dedicated Financial Advisor Offers. By David Bautz PhD. Wall Street Stock Market Finance report prediction for the future.

Buy or sell Viking Therapeutics stock. The warrants have an exercise price of 150 and are exercisable until Apr. Its an integral part of the Zacks Rank and a critical part in effective stock evaluation.

Aiv Stock Predictions